Analytical Data
-
Gene name
RPL7A
- Application
-
Alternative Names
RPL7A;SURF-3;SURF3;Large ribosomal subunit Protein eL8
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P62424
-
Expression Region
1-266aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMPKGKKA KGKKVAPAPA VVKKQEAKKV VNPLFEKRPK NFGIGQDIQP KRDLTRFVKW PRYIRLQRQR AILYKRLKVP PAINQFTQAL DRQTATQLLK LAHKYRPETK QEKKQRLLAR AEKKAAGKGD VPTKRPPVLR AGVNTVTTLV ENKKAQLVVI AHDVDPIELV VFLPALCRKM GVPYCIIKGK ARLGRLVHRK TCTTVAFTQV NSEDKGALAK LVEAIRTNYN DRYDEIRRHW GGNVLGPKSV ARIAKLEKAK AKELATKLG
-
Molecular Weight
32 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RPL7A (Ribosomal Protein L7a) is a vital component of the ribosomal machinery, playing a crucial role in protein synthesis and cellular function. It is encoded by the RPL7A gene, which is highly conserved across eukaryotic species. Research has shown that RPL7A is involved in various cellular processes beyond ribosome biogenesis, including cell proliferation, differentiation, and apoptosis. Its expression levels are often correlated with cancer progression, making it a potential biomarker and therapeutic target in oncology. Studies indicate that RPL7A can influence the assembly of ribosomal subunits and modulate the activity of other ribosomal proteins, emphasizing its importance in maintaining the integrity of protein synthesis. Given its multifunctional nature, recombinant RPL7A protein has gained attention in the scientific community. Producing RPL7A in a recombinant form enables researchers to study its structure-function relationships, signaling pathways, and interactions with other cellular molecules in a controlled environment. Furthermore, recombinant RPL7A could be instrumental in developing novel therapeutic strategies, enhancing our understanding of its role in various diseases, especially cancers. Overall, the investigation of recombinant RPL7A protein is crucial for uncovering its biological significance and potential applications in medicine and biotechnology.
